Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BKRIY | EXE |
|---|---|---|
| Price | $21.35 | $86.43 |
| Change today | ▲ 0.09% | ▲ 1.06% |
| Market cap | $20.00B | $20.01B |
| Return, 3 months | +6.6% | -2.9% |
| Return, year to date | +14.4% | -20.3% |
| Return, 1 year | +30.5% | -18.0% |
| P/E (TTM) | 13.5 | 7.5 |
| P/B | 1.4 | 1.0 |
| P/E percentile vs own 5y | – | 71st |
| Dividend yield | 4.56% | 3.69% |
| Revenue growth (YoY, latest qtr) | – | -19.7% |
| Net profit growth (YoY) | – | -46.1% |
| Gross margin | – | 54.2% |
| Operating margin | – | 29.3% |
| Net margin | – | 20.4% |
| Return on equity | – | 14.9% |
| Analyst target vs. price | – | +45.2% |
| Analyst buy share | – | 83% |
| RSI (14) | 36 | 39 |
| 30-day volatility | 23.3% | 25.9% |
| Max drawdown, 1 year | -16.5% | -30.4% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
